Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1200studies shown
Showing 313-324 of 1,200
Behavioral study icon
RecruitingNCT07221864

Decoding Emotional Dynamics in Bipolarity

This study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.

In United States
BipolarityBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Laureate Institute for Brain Research, Inc.
Condition
Bipolarity
Other study type icon
RecruitingNCT06257056

Deep Brain Stimulation for Psychosis

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In United States
SchizophreniaOtherFrom 22 Years to 70 Years
Countries
United States
Sponsor
Bradley Lega
Condition
Schizophrenia
Other study type icon
RecruitingNCT06660225

Deep Brain Stimulation for Refractory OCD

This study is recruiting. It focuses on OCD and currently lists participation information in the United States.

In United States
OCDOtherFrom 22 Years to 75 Years
Countries
United States
Sponsor
Nader Pouratian
Condition
OCD
Other study type icon
RecruitingNCT05446805

Depression and Driving

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States
DepressionOtherOver 65 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Depression
Behavioral study icon
RecruitingNCT05570721

Depression, Aging, Stress and Heart Health Study

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States
DepressionBehavioralFrom 44 Years to 55 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Depression
Drug study icon
RecruitingNCT05025605

BXCL501 for schizophrenia

This study is recruiting in the United States. It is testing BXCL501 for schizophrenia.

In United States
Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Condition
Bipolarity, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.

United States | Clinical Trials | HopeStage Research